These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30177812)

  • 1. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects.
    Ahmad F; Das D; Kommaddi RP; Diwakar L; Gowaikar R; Rupanagudi KV; Bennett DA; Ravindranath V
    Sci Rep; 2018 Sep; 8(1):13119. PubMed ID: 30177812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.
    Liang B; Duan BY; Zhou XP; Gong JX; Luo ZG
    J Biol Chem; 2010 Sep; 285(36):27737-44. PubMed ID: 20595388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
    Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G
    Mol Brain; 2014 Sep; 7():65. PubMed ID: 25213836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model.
    Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G
    J Neurosci; 2013 May; 33(19):8423-41. PubMed ID: 23658180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated Local Protein Synthesis in the Brain Synaptosomes of a Mouse Model for Alzheimer's Disease.
    Cefaliello C; Penna E; Barbato C; Di Ruberto G; Mollica MP; Trinchese G; Cigliano L; Borsello T; Chun JT; Giuditta A; Perrone-Capano C; Miniaci MC; Crispino M
    Mol Neurobiol; 2020 Mar; 57(3):1529-1541. PubMed ID: 31784883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
    Garad M; Edelmann E; Leßmann V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
    Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
    J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
    Jiang H; Niu F; Zheng Y; Xu Y
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The upside of APP at synapses.
    Hoe HS; Lee HK; Pak DT
    CNS Neurosci Ther; 2012 Jan; 18(1):47-56. PubMed ID: 21199446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease.
    Tan VTY; Mockett BG; Ohline SM; Parfitt KD; Wicky HE; Peppercorn K; Schoderboeck L; Yahaya MFB; Tate WP; Hughes SM; Abraham WC
    Mol Brain; 2018 Feb; 11(1):7. PubMed ID: 29426354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
    Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
    Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer's disease animal model.
    Györffy BA; Tóth V; Török G; Gulyássy P; Kovács RÁ; Vadászi H; Micsonai A; Tóth ME; Sántha M; Homolya L; Drahos L; Juhász G; Kékesi KA; Kardos J
    Cell Mol Life Sci; 2020 Dec; 77(24):5243-5258. PubMed ID: 32034429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.